P2RY2 3'UTR Lenti-reporter-GFP Vector

Availability

Please contact us every day between 9am-6pm local time to check the availability and/or to request a quote. For larger quantities a discount may apply.
Ordering

If you wish to order this product, please include the catalogue number #MT-h67255 in your purchase order among with your shipping and billing information.
Technical file

Please contact us to request the latest datasheet, protocol, certificate of analysis and SDS files.
Notes

Designed for Research Use Only. Manufactured in Canada.
Other products
Description

Lenti kit or vector with CMV or EF promotors for producing Lentivirus (lenti-, Latin for "slow") or lentiviral particles in 293t cells. Lentiviruses are characterized by a long incubation period and often Puro selected. Lentiviruses can deliver a significant amount of viral RNA into the DNA of the host cell and have the unique ability among retroviruses of being able to infect non-dividing cells. They are one of the most efficient methods of a gene delivery vector. The are packaged in HEK 293T cells to get the highest possible lentiviral titers of 108 IFU/ml. The Luc reporter is the expression of the firefly luciferase gene. Puro stands for puromicin selection.

Gene target

P2RY2 3'UTR reporter-GFP Vector
Gene symbol

P2RY2
Short name

P2RY2 3'UTR -reporter-GFP Vector
Technique

lenti, Lentivectors and viral particles, Vectors
Label

gfp
Alternative name

purinergic receptor P2Y, G-protein coupled, 2 3'UTR lentiviral-detector-Green Fluorescent integrating Desoxyribonucleic acid sequence
Alternative to gene target

purinergic receptor P2Y, G-protein coupled, 2, HP2U and P2RU1 and P2U and P2U1 and P2UR and P2Y2 and P2Y2R, P2RY2 and IDBG-63697 and ENSG00000175591 and 5029, G-protein coupled purinergic nucleotide receptor activity, Plasma membranes, P2ry2 and IDBG-201761 and ENSMUSG00000032860 and 18442, P2RY2 and IDBG-635267 and ENSBTAG00000039050 and 282638
Virus

lenti

Name

Artificial Gene Fusion
Concept

Scope note: The in vitro fusion of GENES by RECOMBINANT DNA techniques to analyze protein behavior or GENE EXPRESSION REGULATION, or to merge protein functions for specific medical or industrial uses.
Tree numbers
- E05.393.220.250
Qualifiers

drug effects, methods, radiation effects